ArriVent BioPharma Ratios (2023-2026) | AVBP

Ratios Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Efficiency
Assets Average (Quarter) 245.47M318.35M300.78M283.83M245.22M242.50M298.03M329.86M341.23M
Equity Average (Quarter) -107.77M-125.53M-142.90M82.27M307.19M287.08M267.57M230.10M226.21M277.43M306.11M315.60M
Invested Capital (Quarter) -97.09M-118.46M-132.60M-153.19M317.72M296.66M277.49M257.65M202.54M249.87M305.00M307.22M323.98M
Leverage & Solvency
Equity Ratio (Quarter) -0.940.970.960.950.940.940.930.930.920.93
Valuation
Enterprise Value (Quarter) -124.30M-317.39M-298.67M-282.86M-213.87M-331.71M-235.69M-300.27M-312.82M-590.68M
Return Ratios
Return on Capital Employed (Quarter) -35.28%-28.15%-32.81%-35.38%-60.45%-66.56%-58.75%-58.42%-49.61%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%
Return on Equity (Quarter) 0.00%-0.01%0.00%0.00%0.00%-0.01%-0.01%-0.01%-0.01%0.00%